These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3221259)

  • 21. Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory lymphoma.
    McLaughlin P; Cabanillas F; Bedikian AY; Bodey GP
    Cancer Treat Rep; 1983 May; 67(5):507-8. PubMed ID: 6850666
    [No Abstract]   [Full Text] [Related]  

  • 22. Phase I study of diaziquone.
    Frytak S; Eagan RT; Ames MM; Creagan ET; Nichols WC
    Cancer Treat Rep; 1984; 68(7-8):975-8. PubMed ID: 6744349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory small cell carcinoma of the lung.
    Fuks JZ; Aisner J; Van Echo DA; Levitt M; Ihde DC; Carney D; Wiernik PH
    Am J Clin Oncol; 1983 Apr; 6(2):171-3. PubMed ID: 6299094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of patients with recurrent primary brain tumors with AZQ.
    Schold SC; Friedman HS; Bjornsson TD; Falletta JM
    Neurology; 1984 May; 34(5):615-9. PubMed ID: 6538653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response variability of human brain tumors to AZQ in tissue culture.
    Kornblith PL; Rosa L; Bona JD; Edwards JA; Matuzic N; Hirschfeld A; Hawkins C
    J Neurooncol; 1986; 4(1):49-54. PubMed ID: 3746385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase II study of aziridinylbenzoquinone (AZQ) in advanced large bowel carcinoma.
    Rubin J; van Hazel GA; Schutt AJ; Moertel CG; O'Connell MJ
    Am J Clin Oncol; 1982 Oct; 5(5):539-40. PubMed ID: 7180832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II clinical evaluation of AZQ in colorectal cancer.
    Bedikian AY; Stroehlein JR; Karlin DA; Korinek J; Bodey GP
    Am J Clin Oncol; 1982 Oct; 5(5):535-7. PubMed ID: 7180831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I study of aziridinylbenzoquinone (NSC 182986).
    Bedikian AY; Bodey GP; Burgess MA; Freireich EJ
    Cancer Clin Trials; 1981; 4(4):459-63. PubMed ID: 7318128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase II study of diaziquone in childhood leukemia: a report from the Children's Cancer Study Group.
    Ettinger LJ; Krailo M; Ruccione KS; Krivit W; Hammond GD
    Am J Pediatr Hematol Oncol; 1988; 10(1):18-22. PubMed ID: 3189713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous BCNU and AZQ in patients with recurrent malignant gliomas.
    Yung WK; Harris MI; Bruner JM; Feun LG
    J Neurooncol; 1989 Sep; 7(3):237-40. PubMed ID: 2795118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II clinical evaluation of AZQ in metastatic breast cancer.
    Yap HY; Bedikian AY; Schell FC; Blumenschein GR; Bodey GP
    Am J Clin Oncol; 1983 Feb; 6(1):31-3. PubMed ID: 6837505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase II study of diaziquone in children with recurrent or progressive solid tumors. Report from the Childrens Cancer Study Group.
    Ettinger LJ; Ru N; Krailo MD; Ruccione KS; Krivit WA; Hammond GD
    Am J Pediatr Hematol Oncol; 1990; 12(3):301-5. PubMed ID: 2240475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase I trial of high-dose diaziquone and autologous bone marrow transplantation: an Illinois Cancer Council study.
    Stiff PJ; McKenzie RS; Potempa LD; Albain K; Koch D; Braud E; Bansal VK; Weidner MK; Lanzotti VJ; Chun HG
    J Clin Oncol; 1991 Aug; 9(8):1487-94. PubMed ID: 2072148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High dose AZQ in renal cancer. A Southwest Oncology Group phase II study.
    Stephens RL; Kirby R; Crawford ED; Bukowski R; Rivkin SE; O'Bryan RM
    Invest New Drugs; 1986; 4(1):57-9. PubMed ID: 3700042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I trial and pharmacokinetics of aziridinylbenzoquinone (NSC 182986) in humans.
    Schilsky RL; Kelley JA; Ihde DC; Howser DM; Cordes RS; Young RC
    Cancer Res; 1982 Apr; 42(4):1582-6. PubMed ID: 7060028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase II study of diaziquone in children with recurrent or progressive primary brain tumors: a report from the Childrens Cancer Study Group.
    Ettinger LJ; Ru N; Krailo M; Ruccione KS; Krivit W; Hammond GD
    J Neurooncol; 1990 Aug; 9(1):69-76. PubMed ID: 2213117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I evaluation of diaziquone in childhood cancer. A Pediatric Oncology Group study.
    Falletta JM; Cushing B; Lauer S; Bell B; Mahoney DH; Castleberry R; Krance RA
    Invest New Drugs; 1990 May; 8(2):167-70. PubMed ID: 2384303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aziridinylbenzoquinone (AZQ) in advanced breast cancer: a Cancer and Leukemia group B phase II trial.
    Budman DR; Forastiere A; Perloff M; Perry M; Aisner J; Weinberg V; Wood W
    Cancer Treat Rep; 1982 Oct; 66(10):1875-6. PubMed ID: 7127327
    [No Abstract]   [Full Text] [Related]  

  • 39. AZQ therapy in patients with disseminated malignant melanoma.
    Yap BS; Bedikian AY; Burgess MA; Bodey GP
    Am J Clin Oncol; 1982 Dec; 5(6):623-5. PubMed ID: 7165003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II trial of aziridinylbenzoquinone (AZQ) in head and neck cancer.
    Forastiere AA; Crain SM; Callahan K; Van Echo D; Mattox D; Thant M; Von Hoff DD; Wiernik PH
    Cancer Treat Rep; 1982 Dec; 66(12):2097-8. PubMed ID: 6892491
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.